{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:29:24Z","timestamp":1774085364841,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.diabres.2017.10.023","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T15:45:53Z","timestamp":1509464753000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients"],"prefix":"10.1016","volume":"135","author":[{"given":"Carlo Bruno","family":"Giorda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Forlani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Manti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6801-9694","authenticated-orcid":false,"given":"Arianna","family":"Mazzotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"De Cosmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Chiara","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Nicolucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Di Bartolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Ceriello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Guida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Tartaglino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2017.10.023_b0005","article-title":"NAFLD and diabetes mellitus","author":"Tilg","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.diabres.2017.10.023_b0010","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ajg.2014.132","article-title":"Mortality from chronic liver diseases in diabetes","volume":"109","author":"Zoppini","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.diabres.2017.10.023_b0015","doi-asserted-by":"crossref","first-page":"2931985","DOI":"10.1155\/2016\/2931985","article-title":"The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes","volume":"2016","author":"Forlani","year":"2016","journal-title":"J Diabetes Res"},{"issue":"4","key":"10.1016\/j.diabres.2017.10.023_b0020","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2878","article-title":"Occurrence over time and regression of non alcoholic fatty liver disease in type 2 diabetes","volume":"33","author":"Giorda","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"10.1016\/j.diabres.2017.10.023_b0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00330-010-1905-5","article-title":"The diagnostic accuracy of US, CT, MRI and 1H-MRS for the 2011. Evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis","volume":"21","author":"Bohte","year":"2011","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.diabres.2017.10.023_b0030","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1478-3231.2011.02482.x","article-title":"Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalence and correlated factors","volume":"31","author":"Leite","year":"2011","journal-title":"Liver Int"},{"issue":"11","key":"10.1016\/j.diabres.2017.10.023_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2009.06.007","article-title":"Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Hossain","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.diabres.2017.10.023_b0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.numecd.2006.08.004","article-title":"Diabetes and liver disease: an ominous association","volume":"17","author":"Moscatiello","year":"2007","journal-title":"Nutr Metab Cardiovas Dis"},{"issue":"2","key":"10.1016\/j.diabres.2017.10.023_b0045","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1210\/jc.2012-3093","article-title":"Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications","volume":"98","author":"Targher","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.diabres.2017.10.023_b0050","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoSMedicine"},{"issue":"9","key":"10.1016\/j.diabres.2017.10.023_b0055","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.diabres.2017.10.023_b0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"2","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.diabres.2017.10.023_b0065","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis patients with HIV\/HCV co-infection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.diabres.2017.10.023_b0070","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Use of the FIB4 index for non-invasive evaluation of fibrosis in non-alcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.diabres.2017.10.023_b0075","first-page":"1388","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"6 Volume 64","author":"European Association for the Study of the Liver (EASL)","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2017.10.023_b0080","doi-asserted-by":"crossref","first-page":"957105","DOI":"10.1155\/2015\/957105","article-title":"Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus","volume":"2015","author":"Russo","year":"2015","journal-title":"Int J Endocrinol"},{"issue":"9","key":"10.1016\/j.diabres.2017.10.023_b0085","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/ndt\/gfv101","article-title":"Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative","volume":"30","author":"De Cosmo","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.diabres.2017.10.023_b0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00592-014-0688-6","article-title":"Trends over 8 years in quality of diabetes care: results of the AMD Annals continuous quality improvement initiative","volume":"52","author":"Rossi","year":"2015","journal-title":"Acta Diabetol"},{"issue":"5","key":"10.1016\/j.diabres.2017.10.023_b0095","first-page":"721","article-title":"High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients","volume":"15","author":"Arab","year":"2016","journal-title":"Ann Hepatol"},{"issue":"25","key":"10.1016\/j.diabres.2017.10.023_b0100","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4254\/wjh.v7.i25.2610","article-title":"Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease","volume":"7","author":"Puchakayala","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.diabres.2017.10.023_b0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbacli.2014.09.001","article-title":"Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients","volume":"3","author":"Goh","year":"2014","journal-title":"BBA Clin"},{"issue":"1","key":"10.1016\/j.diabres.2017.10.023_b0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/apt.13405","article-title":"Sirlin CB and Loomba R. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE","volume":"43","author":"Doycheva","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"17","key":"10.1016\/j.diabres.2017.10.023_b0115","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1517\/14656560903391714","article-title":"Biphasic insulin aspart in the treatment of type 2 diabetes mellitus","volume":"10","author":"Cucinotta","year":"2009","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.diabres.2017.10.023_b0120","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jhep.2010.11.007","article-title":"Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?","volume":"54","author":"Targher","year":"2011","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.diabres.2017.10.023_b0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jceh.2015.02.002","article-title":"The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis","volume":"5","author":"Sharma","year":"2015","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"10.1016\/j.diabres.2017.10.023_b0130","doi-asserted-by":"crossref","first-page":"10146","DOI":"10.1038\/s41598-017-09256-4","article-title":"Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS","volume":"7","author":"Ochi","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.diabres.2017.10.023_b0135","doi-asserted-by":"crossref","first-page":"e76161","DOI":"10.1371\/journal.pone.0076161","article-title":"Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease","volume":"8","author":"Hashiba","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.diabres.2017.10.023_b0140","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00592-011-0293-x","article-title":"HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas","volume":"48","author":"Soverini","year":"2011","journal-title":"Acta Diabetol"},{"issue":"5","key":"10.1016\/j.diabres.2017.10.023_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int J Mol Sci"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717305946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717305946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:06:46Z","timestamp":1759172806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822717305946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":29,"alternative-id":["S0168822717305946"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2017.10.023","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2017.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}